Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ZYDUSLIFE stock hub

NSE/ZYDUSLIFE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ZYDUSLIFEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

945.9B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ZYDUSLIFE

In the news

Latest news · NSE/ZYDUSLIFE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22

P25 24.9P50 32.4P75 45.7

Trailing P/E19.2

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC15.3

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ZYDUSLIFE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

INR

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	27,917
Employees Change	996%
Employees Change Percent	3.7
Enterprise value	INR 999.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE010B01027
Last refreshed	2026-05-10
Market cap	INR 945.9B
Price	INR 939
Price currency	INR
Rev Per Employee	9,345,309.31x
Sector	Healthcare
Sic	2834
Symbol	nse/ZYDUSLIFE
Website	https://zyduslife.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.22%
EV Earnings	20.24x
EV/EBIT	15.65x
EV/EBITDA	13.53x
EV/Sales	3.83x
Forward P/E	22.04x
P/B ratio	3.37x
P/E ratio	19.16x
P/S ratio	3.63x
PE Ratio10 Y	22.38x
PE Ratio3 Y	22.76x
PE Ratio5 Y	20.13x
PEG ratio	3.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.12%
EBITDA Margin	27.89%
Gross margin	72.35%
Gross Profit	INR 188.8B
Gross Profit Growth	19.24%
Gross Profit Growth Q	36.42%
Gross Profit Growth3 Y	22.84%
Gross Profit Growth5 Y	14.19%
Net Income	INR 49.4B
Net Income Growth	8.85%
Net Income Growth Q	1.82%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	33.81%
Net Income Growth5 Y	21.74%
Pretax Margin	25.78%
Profit Margin	18.93%
Profit Per Employee	INR 1.8M
Profitable Years	22
Roa5y	8.27
Roe5y	15.98
ROIC	15.34
Roic5y	14.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.34%
Cagr15y	12.85%
Cagr1y	7.18%
Cagr20y	16.97%
Cagr3y	22.95%
Cagr5y	10.05%
Div CAGR10	16.44%
Div CAGR3	63.86%
Div CAGR5	9.46%
EPS Growth	8.97
EPS Growth Q	1.87
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	34.36
EPS Growth5 Y	22.17
Revenue Growth	17.27x
Revenue Growth Q	30.28x
Revenue Growth Quarters	15x
Revenue Growth Years	8x
Revenue Growth3 Y	16.66x
Revenue Growth5 Y	11.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 70.7B
Debt	INR 96.4B
Debt EBITDA	INR 1.32
Debt Equity	INR 0.34
Equity	INR 280.9B
Interest Coverage	19.66
Net Cash	INR -25.7B
Net Cash By Market Cap	INR -2.71
Net Debt EBITDA	INR 0.35
Net Debt Equity	INR 0.09
Tangible Book Value	INR 93.4B
Tangible Book Value Per Share	INR 92.83
WACC	5.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.11%
Dividend Growth	266.67%
Dividend Growth Years	1%
Dividend per share	INR 11
Dividend Years	25
Dividend Yield	1.17%
Last Dividend	INR 11

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	219.99%
1Y total return	7.18%
200-day SMA	942.8
3Y total return	85.88%
50-day SMA	908.7
50-day SMA vs 200-day SMA	50under200
5Y total return	61.4%
All Time High	1,324.3
All Time High Change	-29.09%
All Time High Date	2024-08-09
All Time Low	5.53
All Time Low Change	16,870.9%
All Time Low Date	2001-07-25
ATR	21.94
Beta	0.32
Beta1y	0.58
Beta2y	0.43
Ch YTD	2.7
High	953
High52	1,059.1
High52 Date	2025-09-19
High52ch	-11.34%
Low	935.6
Low52	835.5
Low52 Date	2026-04-02
Low52ch	12.39%
Ma50ch	3.33%
Price vs 200-day SMA	-0.4%
RSI	57.83
RSI Monthly	54.69
RSI Weekly	54.32
Sharpe ratio	0.25x
Sortino ratio	0.63
Total Return	1.28%
Tr YTD	2.7
Tr15y	513.22%
Tr1m	7.5%
Tr1w	4.06%
Tr3m	5.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 62.9B
Operating Income Growth	15.01
Operating Income Growth Q	32.42
Operating Income Growth3 Y	34.37
Operating Income Growth5 Y	19.55
Operating margin	24.12

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	249,557,138%
Shares Insiders	75.03%
Shares Institutions	14.22%
Shares Out	1,006,233,990
Shares Qo Q	-0.02%
Shares Yo Y	-0.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	734,299.45x
Bv Per Share	251.5
Ch10y	195.3
Ch15y	438.7
Ch1m	7.5
Ch1w	4.06
Ch1y	5.96
Ch20y	1,810.6
Ch3m	5.73
Ch3y	81.63
Ch5y	55.67
Ch6m	-0.54
Change	-0.14%
Change From Open	0.1
Close	940.3
Days Gap	-0.24
Depreciation Amortization	9,841,750,000
Dollar Volume	604,423,032
Earnings Date	2026-05-19
EBIT	INR 62.9B
EBITDA	INR 72.8B
EPS	INR 49.07
F Score	2
Fiscal Year End	March
Founded	1,952
Graham Number	526.96438
Graham Upside	-43.88
Income Tax	INR 17B
Is Primary Listing	1
Last Earnings Date	2026-02-09
Last Report Date	2025-12-31
Last Split Date	2015-10-06
Last Split Type	Forward
Lynch Fair Value	INR 1,067
Lynch Upside	13.64
Ma150	925.7
Ma150ch	1.44%
Ma20	925.8
Ma20ch	1.43%
Next Earnings Date	2026-05-19
Open	938.1
Payment Date	2025-09-11
Position In Range	19.77
Price Date	2026-05-08
Price EBITDA	INR 13
Ptbv Ratio	10.13
Relative Volume	0.89x
Revenue	260,893,000,000x
Tax By Revenue	6.51x
Tax Rate	25.27%
Tr20y	2,200.49%
Tr6m	-0.54%
Volume	643,688

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/ZYDUSLIFE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$11.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.5%

1 consecutive years of growth

Total shareholder yield

+1.3%

Dividend yield + buyback yield combined

Performance

NSE/ZYDUSLIFE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ZYDUSLIFE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.2%

Share of float held by funds and institutions

Insider ownership

+75.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

NSE/ZYDUSLIFE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.8

Neutral momentum band

Price vs 200-day MA

-0.4%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

0.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ZYDUSLIFE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ZYDUSLIFE stock rating?

nse/ZYDUSLIFE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ZYDUSLIFE analysis?

The full report lives at /stocks/nse/ZYDUSLIFE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ZYDUSLIFE?

The latest report frames nse/ZYDUSLIFE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ZYDUSLIFE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.